The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine
NCT01677325 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2012-09-05
Summary
To investigate in subjects with non-alcoholic fatty liver disease the direct effects of a Chinese herb formula.
Conditions
- NAFLD( Non-alcoholic Fatty Liver Disease )
Interventions
- DRUG
-
Chinese herb (YiQiSanJu)
Chinese herb formula:Huangqi,huanglian,yinchen,ect
Sponsors & Collaborators
-
Fudan University
lead OTHER
Principal Investigators
-
Wen-Jian Wang, Ph.D,MD · Huashan Hospital, affliated to Fudan University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2007-01-31
- Completion
- 2008-01-31
More Related Trials
-
Idiopathic Pulmonary Fibrosis Cohort of TCM
NCT07162870 ·Status: NOT_YET_RECRUITING
-
Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome
NCT06703788 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
NCT05072990 ·Status: COMPLETED
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186 ·Status: UNKNOWN ·Phase: PHASE2
-
Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms
NCT01844050 ·Status: COMPLETED ·Phase: NA
-
The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B
NCT03018821 ·Status: UNKNOWN ·Phase: NA
-
Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD
NCT05523648 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution
NCT04853082 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Yiqi Fuyuan Paste Formula in Chronic Fatigue Syndrome: A Randomized Double-Blind Controlled Clinical Trial.
NCT07320937 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
NCT00965471 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China
NCT07196917 ·Status: NOT_YET_RECRUITING
-
A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients
NCT07136935 ·Status: RECRUITING ·Phase: NA
-
the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake
NCT01873014 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Clinical Research of Traditional Chinese Medicine Compound Formulas
NCT07153731 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia
NCT01613183 ·Status: UNKNOWN ·Phase: NA
-
REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
NCT06577753 ·Status: RECRUITING
-
the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD
NCT03681249 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
NCT00543426 ·Status: COMPLETED ·Phase: PHASE4
-
the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD
NCT03681704 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of Ruxian Zengsheng No. 1 Decoction
NCT04767620 ·Status: UNKNOWN ·Phase: PHASE2
-
An Examination of Blinding for Chinese Herbal Oral Liquid and Matched Placebo
NCT05483595 ·Status: COMPLETED ·Phase: NA
-
Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver
NCT05076058 ·Status: UNKNOWN ·Phase: NA
-
Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat
NCT01612260 ·Status: UNKNOWN ·Phase: PHASE4
-
Traditional Chinese Medicine for Complications in Critically Ill Patients
NCT05458687 ·Status: UNKNOWN ·Phase: NA
-
Traditional Chinese Medicine for Severe COVID-19
NCT04323332 ·Status: UNKNOWN ·Phase: PHASE3